OPT-Sciences Corporation carries a market capitalization of 18.61M, placing it among publicly traded companies globally.
| Market Cap | 18.61M |
| Enterprise Value | N/A |
OPT-Sciences Corporation currently has 775,585.00 shares outstanding.
| Shares Outstanding | 775,585.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
OPT-Sciences Corporation trades at a trailing price-to-earnings ratio of 8.87. The price-to-sales ratio is 1.74, and the price-to-book ratio stands at 0.90.
| PE Ratio | 8.87 |
| PS Ratio | 1.74 |
| PB Ratio | 0.90 |
| P/TBV Ratio | 0.89 |
| P/FCF Ratio | 7.73 |
| P/OCF Ratio | 8.37 |
OPT-Sciences Corporation maintains a current ratio of 22.24, meaning it holds 22.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 22.24 |
| Quick Ratio | 20.62 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
| Return on Equity (ROE) | 10.69 |
| Return on Assets (ROA) | 10.21 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.55 |
Over the trailing twelve months, OPT-Sciences Corporation has paid 910,992.00 in income taxes, reflecting an effective tax rate of 37.30.
| Income Tax | 910,992.00 |
| Effective Tax Rate | 37.30 |
OPT-Sciences Corporation's stock has gained approximately 22.1374% over the past 52 weeks. The 50-day moving average sits at 20.33, while the 200-day moving average is 20.23.
| Beta (5Y) | N/A |
| 52-Week Price Change | 22.1374% |
| 50-Day Moving Average | 20.33 |
| 200-Day Moving Average | 20.23 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, OPT-Sciences Corporation generated 7.83M in revenue and converted that into 1.53M in net income, yielding earnings per share of 1.97. EBITDA reached 2.14M, while operating income came in at 2.00M.
| Revenue | 7.83M |
| Gross Profit | 3.31M |
| Operating Income | 2.00M |
| Pretax Income | 2.44M |
| Net Income | 1.53M |
| EBITDA | 2.14M |
| EBIT | 2.00M |
| Earnings Per Share (EPS) | 1.97 |
Total book value stands at 15.09M, with working capital of 14.21M providing operational flexibility.
| Cash & Cash Equivalents | 12.34M |
| Total Debt | N/A |
| Net Debt | -2.84M |
| Equity (Book Value) | 15.09M |
| Book Value Per Share | 19.46 |
| Working Capital | 14.21M |
OPT-Sciences Corporation produced 1.62M in operating cash flow over the past twelve months. After subtracting -133,238.00 in capital expenditures, free cash flow totaled 1.49M - equivalent to 1.92 per share.
| Operating Cash Flow | 1.62M |
| Capital Expenditures | -133,238.00 |
| Free Cash Flow | 1.49M |
| FCF Per Share | 1.92 |
OPT-Sciences Corporation operates with a gross margin of 42.27, reflecting its pricing power and cost economics. The operating margin of 25.60 and net profit margin of 19.56 provide insight into operational efficiency.
| Gross Margin | 42.27 |
| Operating Margin | 25.60 |
| Pretax Margin | 31.19 |
| Profit Margin | 19.56 |
| EBITDA Margin | 27.38 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | N/A |
| FCF Yield | 12.93 |
OPT-Sciences Corporation posts an Altman Z-Score of 15.47, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 15.47 |